Browsing by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 34116 to 34135 of 204094 < previous   next >
Control of salmonella infections in animals and prevention of human foodborne salmonella infections / WHO Consultation
( 1994 )
Control of scabies, skin sores and haematuria in children in the Solomon Islands : another role for ivermectin / Gregor Lawrence .... [et al.]
Lawrence, Gregor; Leafasia, Judson; Sheridan, John; Hills, Susan; Wate, Janet; Wate, Christine; Montgomery, Janet; Pandeya, Nirmala; Purdie, David ( 2005 )
Control of schistosoma haematobium morbidity on Pemba Island : validity and efficiency of indirect screening tests / N. J. S. Lwambo ... [et al.]
Lwambo, N. J. S.; Savioli, L; Kisumku, U. M; Alawi, K. S; Bundy, D. A. P ( 1997 )
The control of schistosomiasis : report of a WHO expert committee [meeting held in Geneva from 8 to 13 November 1984]
WHO Expert Committee on the Control of Schistosomiasis; World Health Organization ( 1985 )

Communicates changes in priorities and operational approaches based on the availability of safe and highly effective antischistosomiasis drugs. With emphasis on the feasibility of controlling morbidity due to schistosomiasis, the book combines an in-depth review of clinical and scientific research with an outline of different operational approaches for morbidity control. Advances in parasitological diagnostic techniques, knowledge of human ecology of this disease, and the establishment of specific epidemiological criteria are also covered

The control of schistosomiasis : second report of the WHO Expert Committee [meeting held in Geneva from 8-15 November 1991]
WHO Expert Committee on the Control of Schistosomiasis (1991 : Geneva, Switzerland); World Health Organization ( 1993 )

A comprehensive guide to the technical and practical factors that need to be considered when designing and implementing programmes for the control of schistosomiasis. Noting the success of strategies focused on morbidity control, the report shows how the spectrum of programme goals can now be broadened to include reductions in the prevalence and intensity of established infections and decreases in the intensity of transmission. Throughout, emphasis is placed on knowledge and experiences that can help programme managers establish feasible goals and then select control options in line with the form of infection, its public health importance, the degree and type of morbidity, available resources, and integration into the primary health care system. Information is specific to the different types of schistosomiasis and the distinctive epidemiological features, clinical manifestations, and response to treatment of each. The report has three main parts. The first, which is devoted to strategies for control, gives programme managers a concise, yet complete review of all factors that need to be considered when establishing priorities and deciding on the most appropriate options for control. Emphasis is placed on the many recent advances, including experiences with praziquantel, that have strengthened the tools available for prevention, diagnosis, treatment, and cure. While noting the severe financial constraints faced in many endemic countries, the report cites recent findings and experiences that make it possible for each endemic country to take action against schistosomiasis, even when resources are scarce and health services limited. The second part gives specialists a detailed state-of-the-art review of all technical developments relevant to control. Separate sections describe the distinctive patterns of morbidity and mortality seen in each form of infection, update knowledge about the parasite and its mammalian hosts, and summarize what is known about the snail intermediate host and its susceptibility to control by molluscicides, biological agents, and environmental management. Other sections describe a range of advances in diagnostic tools, from hospital-based radiological investigations to the use of portable ultrasound equipment at the village level, and issue advice on treatmet and retreatment schedules for chemotherapy with praziquantel, metrifonate, and oxamniquine. The final part uses profiles of control programmes in 23 countries to document the feasibility of control and illustrate the diversity of approaches that can be applied according to different national conditions, forms and prevalence of infection, health care systems, and available resources

Control of sexually transmitted diseases
World Health Assembly, 28 ( 1975 )
Control of sexually transmitted diseases
World Health Assembly, 31 ( 1978 )
Control of sexually transmitted diseases
World Health Organization ( 1985 )
World Health Organization ( 1976 )
Control of sexually transmitted diseases: report by the Director-General
World Health Assembly, 31 ( 1978 )
Control of sexually transmitted infections and prevention of HIV transmission: mending a fractured paradigm
Ndowa, Francis; Kamali, Anatoli; Wi, Teodora Elvira; Steen, Richard ( 2009-11-01 )

Control of sexually transmitted infections (STIs) is feasible, leads to improved sexual and reproductive health and contributes to preventing HIV transmission. The most advanced HIV epidemics have developed under conditions of poor STI control, particularly where ulcerative STIs were prevalent. Several countries that have successfully controlled STIs have documented stabilization or reversal of their HIV epidemics. STI control is a public health outcome measured by reduced incidence and prevalence. The means to achieve this include: (i) targeting and outreach to populations at greatest risk; (ii) promoting and providing condoms and other means of prevention; (iii) effective clinical interventions; (iv) an enabling environment; and (v) reliable data. Clinical services include STI case management, screening and management of STIs in sex partners. Syndromic case management is effective for most symptomatic curable STIs and screening strategies exist to detect some asymptomatic infections. Presumptive epidemiologic treatment of sex partners and sex workers complement efforts to interrupt transmission and reduce prevalence. Clinical services alone are insufficient for control since many people with STIs do not attend clinics. Outreach and peer education have been effectively used to reach such populations. STI control requires effective interventions with core populations whose rates of partner change are high enough to sustain transmission. Effective, appropriate targeting is thus necessary and often sufficient to reduce prevalence in the general population. Such efforts are most effective when combined with structural interventions to ensure an enabling environment for prevention. Reliable surveillance and related data are critical for designing and evaluating interventions and for assessing control efforts.

Control of sleeping sickness--time to integrate approaches
Mattock, Nina; Kioy, Deborah ( 2005-08-01 )
Control of smallpox in Delhi Municipal Corporation / by P.H. Jeswani
Jeswani, P. H; World Health Organization; WHO Inter-Country Seminar on Surveillance in Smallpox Eradication (1972 : New Delhi, India) ( 1972 )
The control of smallpox in Greater Bombay / by D.V. Parulekar
Parulekar, D. V; World Health Organization; WHO Inter-Country Seminar on Surveillance in Smallpox Eradication (1972 : New Delhi, India) ( 1972 )
Control of smoking
World Health Organization, Regional Office for the Eastern Mediterranean ( 1987 )
Control of soil-transmitted helminths / Paul C. Beaver
Beaver, Paul Chester; World Health Organization ( 1961 )
The control of syphilis: report communicated by the Government of Viet-Nam
World Health Assembly, 6 ( 1953 )
Control of the Leishmaniases : Report of a WHO Expert Committee = Lutte contre les leishmanioses : Rapport d'un Comité OMS d'experts
World Health Organization ( 1991 )
Control of the leishmaniases : report of a WHO expert committee [meeting held in Geneva from 6 to 10 February 1989]
WHO Expert Committee on the Control of the Leishmaniases; World Health Organization ( 1990 )

Draws together world knowledge about the leishmaniases in order to establish guidelines for control that are specific to the different disease forms, parasite species, reservoir hosts, an vectors found in some 80 countries. The report takes its focus from recent progress in the identification of parasites and vectors as well as major advances in knowledge about the geographical distribution and prevalence of infection. Recommended control measures draw added force from the growing awareness that long-standing endemic foci can suddenly erupt into epidemics. The first main chapter, devoted to the leishmaniases in man, provides a richly detailed account of the seven main forms of clinical disease, their parasites, reservoir hosts, and vectors. The second chapter surveys measures for control, offering advice on the confirmation of diagnosis, passive case detection, active medical surveillance, treatment protocols for each disease form, and measures for the control of reservoir hosts and different species of sandfly. The second half of the book presents guidelines that can, for the first time, support the development of a global policy for control and assist in the establishment of long-term national programmes. Progress in understanding the geographical distribution and prevalence of infection is reflected in a 28-page, country-by-country tabulation of data on the parasites, proven or suspected reservoirs and vectors, and public health implications for different forms of the leishmaniases found in each of 80 countries. Specific control approaches are then outlined for 11 nosogeographical entities, with details on geographical distribution, epidemiological features, reservoir and vector control, and evaluation

Control of the leishmaniases: report of a meeting of the WHO Expert Commitee on the Control of Leishmaniases, Geneva, 22-26 March 2010
WHO Expert Committee on the Control of the Leishmaniases; World Health Organization ( 2010 )
Showing results 34116 to 34135 of 204094 < previous   next >